- Home
- NPKI vs TSHA Comparison
NPKI vs TSHA Comparison
Compare NPKI & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPKI
- TSHA
- Stock Information
- Founded
- NPKI 1932
- TSHA 2019
- Country
- NPKI United States
- TSHA United States
- Employees
- NPKI N/A
- TSHA N/A
- Industry
- NPKI Metal Fabrications
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- NPKI Industrials
- TSHA Health Care
- Exchange
- NPKI Nasdaq
- TSHA Nasdaq
- Market Cap
- NPKI 881.5M
- TSHA 728.4M
- IPO Year
- NPKI N/A
- TSHA 2020
- Fundamental
- Price
- NPKI $10.67
- TSHA $3.22
- Analyst Decision
- NPKI Strong Buy
- TSHA Strong Buy
- Analyst Count
- NPKI 3
- TSHA 7
- Target Price
- NPKI $12.17
- TSHA $8.71
- AVG Volume (30 Days)
- NPKI 712.0K
- TSHA 3.4M
- Earning Date
- NPKI 11-06-2025
- TSHA 08-12-2025
- Dividend Yield
- NPKI N/A
- TSHA N/A
- EPS Growth
- NPKI N/A
- TSHA N/A
- EPS
- NPKI N/A
- TSHA N/A
- Revenue
- NPKI $234,741,000.00
- TSHA $8,098,000.00
- Revenue This Year
- NPKI $19.94
- TSHA N/A
- Revenue Next Year
- NPKI $9.36
- TSHA N/A
- P/E Ratio
- NPKI N/A
- TSHA N/A
- Revenue Growth
- NPKI 6.96
- TSHA N/A
- 52 Week Low
- NPKI $4.76
- TSHA $1.05
- 52 Week High
- NPKI $10.75
- TSHA $3.40
- Technical
- Relative Strength Index (RSI)
- NPKI 70.02
- TSHA 62.46
- Support Level
- NPKI $10.35
- TSHA $3.16
- Resistance Level
- NPKI $10.71
- TSHA $2.99
- Average True Range (ATR)
- NPKI 0.25
- TSHA 0.17
- MACD
- NPKI -0.02
- TSHA 0.02
- Stochastic Oscillator
- NPKI 89.74
- TSHA 73.98
About NPKI NPK International Inc. Common Stock
NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.